1 1235 159 FEASIBILITY AND SAFETY OF INTRADIALYSIS YOGA AND EDUCATION IN MAINTENANCE HEMODIALYSIS PATIENTS. OBJECTIVE: PATIENTS WITH END-STAGE RENAL DISEASE ON MAINTENANCE HEMODIALYSIS ARE MUCH MORE SEDENTARY THAN HEALTHY INDIVIDUALS. THE PURPOSE OF THIS STUDY WAS TO ASSESS THE FEASIBILITY AND SAFETY OF A 12-WEEK INTRADIALYSIS YOGA INTERVENTION VERSUS A KIDNEY EDUCATION INTERVENTION ON THE PROMOTION OF PHYSICAL ACTIVITY. DESIGN AND METHODS: WE RANDOMIZED PARTICIPANTS BY DIALYSIS SHIFT TO EITHER 12-WEEK INTRADIALYSIS YOGA OR AN EDUCATIONAL INTERVENTION. INTRADIALYSIS YOGA WAS PROVIDED BY YOGA TEACHERS TO PARTICIPANTS WHILE RECEIVING HEMODIALYSIS. PARTICIPANTS RECEIVING THE 12-WEEK EDUCATIONAL INTERVENTION RECEIVED A MODIFICATION OF A PREVIOUSLY DEVELOPED COMPREHENSIVE EDUCATIONAL PROGRAM FOR PATIENTS WITH KIDNEY DISEASE (KIDNEY SCHOOL). THE PRIMARY OUTCOME FOR THIS STUDY WAS FEASIBILITY BASED ON RECRUITMENT AND ADHERENCE TO THE INTERVENTIONS AND SAFETY OF INTRADIALYSIS YOGA. SECONDARY OUTCOMES WERE TO DETERMINE THE FEASIBILITY OF ADMINISTERING QUESTIONNAIRES AT BASELINE AND 12 WEEKS INCLUDING THE KIDNEY DISEASE-RELATED QUALITY OF LIFE-36. RESULTS: AMONG 56 ELIGIBLE PATIENTS WHO APPROACHED FOR THE STUDY, 31 (55%) WERE INTERESTED AND CONSENTED TO PARTICIPATION, WITH 18 ASSIGNED TO INTRADIALYSIS YOGA AND 13 TO THE EDUCATIONAL PROGRAM. A TOTAL OF 5 PARTICIPANTS WITHDREW FROM THE PILOT STUDY, ALL FROM THE INTRADIALYSIS YOGA GROUP. TWO OF THESE PARTICIPANTS REPORTED NO FURTHER INTEREST IN PARTICIPATION. THREE WITHDRAWN PARTICIPANTS SWITCHED DIALYSIS TIMES AND THEREFORE COULD NO LONGER RECEIVE INTRADIALYSIS YOGA. AS A RESULT, 13 OF 18 (72%) AND 13 OF 13 (100%) PARTICIPANTS COMPLETED 12-WEEK INTRADIALYSIS YOGA AND EDUCATIONAL PROGRAMS, RESPECTIVELY. THERE WERE NO ADVERSE EVENTS RELATED TO INTRADIALYSIS YOGA. INTERVENTION PARTICIPANTS PRACTICED YOGA FOR A MEDIAN OF 21 SESSIONS (70% PARTICIPATION FREQUENCY), WITH 60% OF PARTICIPANTS PRACTICING AT LEAST 2 TIMES A WEEK. PARTICIPANTS IN THE EDUCATIONAL PROGRAM COMPLETED A MEDIAN OF 30 SESSIONS (83% PARTICIPATION FREQUENCY). OF PARTICIPANTS WHO COMPLETED THE STUDY (N = 26), BASELINE AND 12-WEEK QUESTIONNAIRES WERE OBTAINED FROM 85%. CONCLUSIONS: OUR PILOT STUDY OF 12-WEEK INTRADIALYSIS YOGA AND 12-WEEK EDUCATIONAL INTERVENTION REACHED RECRUITMENT GOALS BUT WITH LESS THAN TARGETED COMPLETION AND ADHERENCE TO INTERVENTION RATES. THIS STUDY PROVIDED VALUABLE FEASIBILITY DATA TO INCREASE FOLLOW-UP AND ADHERENCE FOR FUTURE CLINICAL TRIALS TO COMPARE EFFICACY. 2015 2 838 33 EFFECT OF YOGA ON PHYSICAL AND PSYCHOLOGICAL OUTCOMES IN PATIENTS ON CHRONIC HEMODIALYSIS. INTRODUCTION: PATIENTS ON CHRONIC HEMODIALYSIS SUFFER FROM A MYRIAD OF PROBLEMS ASSOCIATED WITH DIALYSIS INCLUDING INCREASED CARDIOVASCULAR DISEASE, DECONDITIONING, FATIGUE, SLEEP DISTURBANCES, ANXIETY AND DEPRESSION, AND DECREASED HEALTH RELATED QUALITY OF LIFE. YOGA HAS BEEN REPORTED TO HAVE POSITIVE EFFECTS ON DISTRESS AND FUNCTIONAL PERFORMANCE IN PATIENTS WITH CHRONIC DISEASES. THE EFFECT OF YOGA IN PATIENTS ON CHRONIC HEMODIALYSIS IS UNKNOWN. FOR THE PURPOSE OF THIS STUDY, PAPERS WERE REVIEWED TO DETERMINE THE EFFECT OF INTRADIALYSIS YOGA ON DISTRESS AND FUNCTIONAL PERFORMANCE IN PATIENTS UNDERGOING CHRONIC HEMODIALYSIS. METHODS: THIS INTEGRATIVE REVIEW EXAMINED STUDIES PUBLISHED IN PUBMED, CINAHL AND PSYCHINFO. THE SEARCH TERMS INCLUDED: YOGA, HEMODIALYSIS, DIALYSIS. RESULTS: TWO RCTS MET THE CRITERIA. YOGA SHOWED IMPROVEMENT IN SEVERAL OUTCOMES INCLUDING: QUALITY OF LIFE, PAIN, FATIGUE, SLEEP DISTURBANCE, PHYSICAL FUNCTION AS WELL AS A NUMBER OF BIOCHEMICAL VARIABLES. FURTHER WELL DESIGNED RCTS NEED TO BE CONDUCTED. 2019 3 1497 55 INTRADIALYTIC LAUGHTER YOGA THERAPY FOR HAEMODIALYSIS PATIENTS: A PRE-POST INTERVENTION FEASIBILITY STUDY. BACKGROUND: LAUGHTER YOGA CONSISTS OF PHYSICAL EXERCISE, RELAXATION TECHNIQUES AND SIMULATED VIGOROUS LAUGHTER. IT HAS BEEN ASSOCIATED WITH PHYSICAL AND PSYCHOLOGICAL BENEFITS FOR PEOPLE IN DIVERSE CLINICAL AND NON-CLINICAL SETTINGS, BUT HAS NOT YET BEEN TESTED IN A HAEMODIALYSIS SETTING. THE STUDY HAD THREE AIMS: 1) TO EXAMINE THE FEASIBILITY OF CONDUCTING LAUGHTER YOGA FOR PATIENTS WITH END STAGE KIDNEY DISEASE IN A DIALYSIS SETTING; 2) TO EXPLORE THE PSYCHOLOGICAL AND PHYSIOLOGICAL IMPACT OF LAUGHTER YOGA FOR THESE PATIENTS; AND 3) TO ESTIMATE THE SAMPLE SIZE REQUIRED FOR FUTURE RESEARCH. METHODS: PRE/POST INTERVENTION FEASIBILITY STUDY. EIGHTEEN PARTICIPANTS WERE RECRUITED INTO THE STUDY AND LAUGHTER YOGA THERAPISTS PROVIDED A FOUR WEEK INTRADIALYTIC PROGRAM (30-MIN INTERVENTION THREE TIMES PER WEEK). PRIMARY OUTCOMES WERE PSYCHOLOGICAL ITEMS MEASURED AT THE FIRST AND LAST LAUGHTER YOGA SESSION, INCLUDING: QUALITY OF LIFE; SUBJECTIVE WELLBEING; MOOD; OPTIMISM; CONTROL; SELF-ESTEEM; DEPRESSION, ANXIETY AND STRESS. SECONDARY OUTCOMES WERE: BLOOD PRESSURE, INTRADIALYTIC HYPOTENSIVE EPISODES AND LUNG FUNCTION (FORCED EXPIRATORY VOLUME). DIALYSIS NURSES EXPOSED TO THE INTERVENTION COMPLETED A LAUGHTER YOGA ATTITUDES AND PERCEPTIONS SURVEY (N = 11). DATA WERE ANALYSED USING IBM SPSS STATISTICS V22, INCLUDING DESCRIPTIVE AND INFERENTIAL STATISTICS, AND SAMPLE SIZE ESTIMATES WERE CALCULATED USING G*POWER. RESULTS: ONE PARTICIPANT WITHDREW FROM THE STUDY FOR MEDICAL REASONS THAT WERE UNRELATED TO THE STUDY DURING THE FIRST WEEK (94 % RETENTION RATE). THERE WERE NON-SIGNIFICANT INCREASES IN HAPPINESS, MOOD, AND OPTIMISM AND A DECREASE IN STRESS. EPISODES OF INTRADIALYTIC HYPOTENSION DECREASED FROM 19 PRE AND 19 DURING LAUGHTER YOGA TO 4 POST LAUGHTER YOGA. THERE WAS NO CHANGE IN LUNG FUNCTION OR BLOOD PRESSURE. ALL NURSES AGREED OR STRONGLY AGREED THAT LAUGHTER YOGA HAD A POSITIVE IMPACT ON PATIENTS' MOOD, IT WAS A FEASIBLE INTERVENTION AND THEY WOULD RECOMMEND LAUGHTER YOGA TO THEIR PATIENTS. SAMPLE SIZE CALCULATIONS FOR FUTURE RESEARCH INDICATED THAT A MINIMUM OF 207 PARTICIPANTS WOULD BE REQUIRED TO PROVIDE SUFFICIENT POWER TO DETECT CHANGE IN KEY PSYCHOLOGICAL VARIABLES. CONCLUSIONS: THIS STUDY PROVIDES EVIDENCE THAT LAUGHTER YOGA IS A SAFE, LOW-INTENSITY FORM OF INTRADIALYTIC PHYSICAL ACTIVITY THAT CAN BE SUCCESSFULLY IMPLEMENTED FOR PATIENTS IN DIALYSIS SETTINGS. LARGER STUDIES ARE REQUIRED, HOWEVER, TO DETERMINE THE EFFECT OF LAUGHTER YOGA ON KEY PSYCHOLOGICAL VARIABLES. TRIAL REGISTRATION: AUSTRALIAN NEW ZEALAND CLINICAL TRIALS REGISTRY - ACTRN12614001130651 . REGISTERED 23 OCTOBER 2014. 2015 4 1001 29 EFFECTS OF LAUGHTER YOGA ON HEMODIALYSIS PATIENTS' PLASMA-BETA ENDORPHIN LEVELS, PAIN LEVELS AND SLEEP QUALITY: A RANDOMIZED CONTROLLED TRIAL. THIS STUDY EVALUATES THE EFFECTS OF "LAUGHTER YOGA" ON THE PLASMA BETA-ENDORPHIN LEVELS, PAIN LEVELS AND SLEEP QUALITY OF HEMODIALYSIS PATIENTS. IT IS A RANDOMIZED CONTROLLED TRIAL. THE STUDY WAS CARRIED OUT BETWEEN JULY AND OCTOBER 2018. A TOTAL OF 68 PATIENTS RECEIVING HEMODIALYSIS TREATMENT AT TWO DIFFERENT DIALYSIS CENTERS WERE INCLUDED IN THE STUDY. THE DURATION OF THE LAUGHTER YOGA WAS 30 MIN, AND A TOTAL OF 16 SESSIONS WERE PERFORMED ON A TWICE-WEEKLY BASIS. THE DATA WERE COLLECTED BY USING A SOCIO-DEMOGRAPHIC INFORMATION FORM, THE VISUAL ANALOG SCALE AND THE PITTSBURGH SLEEP QUALITY INDEX, AND BLOOD SAMPLES WERE COLLECTED TO DETERMINE BETA-ENDORPHIN LEVELS. FOLLOWING THE LAUGHTER YOGA IMPLEMENTATION, THE PAIN LEVEL OF THE INTERVENTION GROUP PATIENTS SIGNIFICANTLY DECREASED, AND THEIR SLEEP QUALITY SIGNIFICANTLY IMPROVED. NO SIGNIFICANT CHANGE OCCURRED IN THE PATIENTS' BETA-ENDORPHIN LEVELS. LAUGHTER YOGA WAS EFFECTIVE IN REDUCING PAIN AND INCREASING SLEEP QUALITY. 2021 5 940 41 EFFECTS OF 6 MONTHS YOGA PROGRAM ON RENAL FUNCTIONS AND QUALITY OF LIFE IN PATIENTS SUFFERING FROM CHRONIC KIDNEY DISEASE. AIM: TO STUDY THE EFFECT OF 6 MONTHS YOGA PROGRAM IN PATIENTS SUFFERING FROM CHRONIC KIDNEY DISEASE (CKD). MATERIALS AND METHODS: FIFTY-FOUR PATIENTS WITH CKD WERE STUDIED AND DIVIDED INTO TWO GROUPS (YOGA GROUP AND CONTROL GROUP) TO SEE THE EFFECT OF YOGA IN CKD. PATIENTS IN THE YOGA GROUP WERE OFFERED YOGA THERAPY ALONG WITH OTHER CONVENTIONAL TREATMENT MODALITIES, WHILE THE CONTROL GROUP WAS ONLY ON CONVENTIONAL TREATMENT. SUBJECTS IN YOGA GROUP WERE TRAINED TO PERFORM SPECIFIC YOGIC ASANAS FOR AT LEAST 5 DAYS A WEEK FOR 40-60 MIN A DAY. REGULAR MONITORING OF BLOOD PRESSURE, RENAL FUNCTION, REQUIREMENT OF A NUMBER OF DIALYSIS, AND QUALITY OF LIFE (QOL) INDICATORS WERE DONE. FIFTY PATIENTS (YOGA - 25; CONTROL-25) COMPLETED 6 MONTHS FOLLOW-UP. RESULTS: IN YOGA GROUP, A SIGNIFICANT REDUCTION OF SYSTOLIC AND DIASTOLIC BLOOD PRESSURE, SIGNIFICANT REDUCTION IN BLOOD UREA AND SERUM CREATININE LEVELS, AND SIGNIFICANT IMPROVEMENT IN PHYSICAL AND PSYCHOLOGICAL DOMAIN OF THE WORLD HEALTH ORGANIZATION QOL (AS ASSESSED BY BREF QOL SCORES) WERE SEEN AFTER 6 MONTHS. IN CONTROL GROUP, RISE OF BLOOD PRESSURE, DETERIORATION OF RENAL FUNCTION, AND QOL WERE OBSERVED. POSTSTUDY COMPARISON BETWEEN THE TWO GROUPS SHOWED A STATISTICALLY SIGNIFICANT REDUCTION OF BLOOD PRESSURE, NONSIGNIFICANT REDUCTION IN BLOOD UREA AND SERUM CREATININE, AND SIGNIFICANT IMPROVEMENT IN PHYSICAL AND PSYCHOLOGICAL DOMAIN OF QOL IN YOGA GROUP AS COMPARED TO CONTROL GROUP. FOR SUBJECTS IN YOGA GROUP, THE NEED FOR DIALYSIS WAS LESS WHEN COMPARED TO CONTROL GROUP ALTHOUGH THIS DIFFERENCE WAS STATISTICALLY INSIGNIFICANT. EXCEPT FOR INABILITY OF SOME PATIENTS TO PERFORM CERTAIN YOGIC ASANAS NO ADVERSE EFFECT WAS FOUND IN THE STUDY. CONCLUSION: SIX MONTHS YOGA PROGRAM IS SAFE AND EFFECTIVE AS AN ADJUVANT THERAPY IN IMPROVING RENAL FUNCTIONS AND QOL OF CKD PATIENTS. 2017 6 1043 36 EFFECTS OF YOGA INTERVENTIONS ON FATIGUE: A META-ANALYSIS. BACKGROUND. RESEARCHERS AIMED AT SYSTEMATICALLY REVIEWING AND META-ANALYZING THE EFFECTIVENESS OF YOGA INTERVENTIONS FOR FATIGUE. METHODS. PUBMED/MEDLINE WAS SEARCHED UNTIL JANUARY 2012 FOR CONTROLLED CLINICAL STUDIES. TWO REVIEWERS INDEPENDENTLY EXTRACTED THE DATA. THE METHODOLOGICAL QUALITY OF THE STUDIES WAS ASSESSED. A META-ANALYSIS WAS PERFORMED. RESULTS. NINETEEN CLINICAL STUDIES (TOTAL N = 948) WERE INCLUDED IN THIS REVIEW. INVESTIGATED YOGA STYLES INCLUDED HATHA, IYENGAR, ASANAS, PATANJALI, SAHAJA, AND TIBETAN YOGA. PARTICIPANTS WERE SUFFERING FROM CANCER, MULTIPLE SCLEROSIS, DIALYSIS, CHRONIC PANCREATITIS, FIBROMYALGIA, ASTHMA, OR WERE HEALTHY. YOGA HAD A SMALL POSITIVE EFFECT ON FATIGUE (SMD = 0.27, 59% CI = 0.23-0.31). SEVEN STUDIES RECEIVED 4 POINTS ON THE JADAD SCORE. THERE WERE BASELINE DIFFERENCES IN AT LEAST 5 STUDIES. CONCLUSION. OVERALL, THE EFFECTS OF YOGA INTERVENTIONS ON FATIGUE WERE ONLY SMALL, PARTICULARLY IN CANCER PATIENTS. ALTHOUGH YOGA IS GENERALLY A SAFE THERAPEUTIC INTERVENTION AND EFFECTIVE TO ATTENUATE OTHER HEALTH-RELATED SYMPTOMS, THIS META-ANALYSIS WAS NOT ABLE TO DEFINE THE POWERFUL EFFECT OF YOGA ON PATIENTS SUFFERING FROM FATIGUE. TREATMENT EFFECTS OF YOGA COULD BE IMPROVED IN WELL-DESIGNED FUTURE STUDIES. ACCORDING TO THE GRADE RECOMMENDATIONS ASSESSING THE OVERALL QUALITY OF EVIDENCE, THERE IS A MODERATE EFFECT OF THE CONFIDENCE PLACED IN THE ESTIMATES OF THE EFFECTS DISCUSSED HERE. 2012 7 90 38 A MODIFIED YOGA-BASED EXERCISE PROGRAM IN HEMODIALYSIS PATIENTS: A RANDOMIZED CONTROLLED STUDY. AIM: TO EVALUATE THE EFFECTS OF A YOGA-BASED EXERCISE PROGRAM ON PAIN, FATIGUE, SLEEP DISTURBANCE, AND BIOCHEMICAL MARKERS IN HEMODIALYSIS PATIENTS. MATERIALS AND METHODS: IN 2004 A RANDOMIZED CONTROLLED TRIAL WAS CARRIED OUT IN THE OUTPATIENT HEMODIALYSIS UNIT OF THE NEPHROLOGY DEPARTMENT, ULUDAG UNIVERSITY FACULTY OF MEDICINE. CLINICALLY STABLE HEMODIALYSIS PATIENTS (N=37) WERE INCLUDED AND FOLLOWED IN TWO GROUPS: THE MODIFIED YOGA-BASED EXERCISE GROUP (N=19) AND THE CONTROL GROUP (N=18). YOGA-BASED EXERCISES WERE DONE IN GROUPS FOR 30 MIN/DAY TWICE A WEEK FOR 3 MONTHS. ALL OF THE PATIENTS IN THE YOGA AND CONTROL GROUPS WERE GIVEN AN ACTIVE RANGE OF MOTION EXERCISES TO DO FOR 10 MIN AT HOME. THE MAIN OUTCOME MEASURES WERE PAIN INTENSITY (MEASURED BY THE VISUAL ANALOGUE SCALE, VAS), FATIGUE (VAS), SLEEP DISTURBANCE (VAS), AND GRIP STRENGTH (MMHG); BIOCHEMICAL VARIABLES-- UREA, CREATININE, CALCIUM, ALKALINE PHOSPHATASE, PHOSPHORUS, CHOLESTEROL, HDL-CHOLESTEROL, TRIGLYCERIDE, ERYTHROCYTE, HEMATOCRIT--WERE EVALUATED. RESULTS: AFTER A 12-WEEK INTERVENTION, SIGNIFICANT IMPROVEMENTS WERE SEEN IN THE VARIABLES: PAIN -37%, FATIGUE -55%, SLEEP DISTURBANCE -25%, GRIP STRENGTH +15%, UREA -29%, CREATININE -14%, ALKALINE PHOSPHATASE -15%, CHOLESTEROL -15%, ERYTHROCYTE +11%, AND HEMATOCRIT COUNT +13%; NO SIDE-EFFECTS WERE SEEN. IMPROVEMENT OF THE VARIABLES IN THE YOGA-BASED EXERCISE PROGRAM WAS FOUND TO BE SUPERIOR TO THAT IN THE CONTROL GROUP FOR ALL THE VARIABLES EXCEPT CALCIUM, PHOSPHORUS, HDL-CHOLESTEROL AND TRIGLYCERIDE LEVELS. CONCLUSION: A SIMPLIFIED YOGA-BASED REHABILITATION PROGRAM IS A COMPLEMENTARY, SAFE AND EFFECTIVE CLINICAL TREATMENT MODALITY IN PATIENTS WITH END-STAGE RENAL DISEASE. 2007 8 2860 33 YOGA-BASED EXERCISE IMPROVES HEALTH-RELATED QUALITY OF LIFE AND MENTAL WELL-BEING IN OLDER PEOPLE: A SYSTEMATIC REVIEW OF RANDOMISED CONTROLLED TRIALS. OBJECTIVE: HEALTH-RELATED QUALITY OF LIFE (HRQOL) AND MENTAL WELL-BEING ARE ASSOCIATED WITH HEALTHY AGEING. PHYSICAL ACTIVITY POSITIVELY IMPACTS BOTH HRQOL AND MENTAL WELL-BEING. YOGA IS A PHYSICAL ACTIVITY THAT CAN BE MODIFIED TO SUITS THE NEEDS OF OLDER PEOPLE AND IS GROWING IN POPULARITY. WE CONDUCTED A SYSTEMATIC REVIEW WITH META-ANALYSIS TO DETERMINE THE IMPACT OF YOGA-BASED EXERCISE ON HRQOL AND MENTAL WELL-BEING IN PEOPLE AGED 60+. METHODS: SEARCHES WERE CONDUCTED FOR RELEVANT TRIALS IN THE FOLLOWING ELECTRONIC DATABASES; MEDLINE, EMBASE, COCHRANE CENTRAL REGISTER OF CONTROLLED TRIALS, CINAHL, ALLIED AND COMPLEMENTARY MEDICINE DATABASE, PSYCINFO AND THE PHYSIOTHERAPY EVIDENCE DATABASE (PEDRO) FROM INCEPTION TO JANUARY 2017. TRIALS THAT EVALUATED THE EFFECT OF PHYSICAL YOGA ON HRQOL AND/OR ON MENTAL WELL-BEING IN PEOPLE AGED 60+ YEARS WERE INCLUDED. DATA ON HRQOL AND MENTAL WELL-BEING WERE EXTRACTED. STANDARDISED MEAN DIFFERENCES AND 95% CONFIDENCE INTERVALS (CI) WERE CALCULATED USING RANDOM EFFECTS MODELS. METHODOLOGICAL QUALITY OF TRIALS WAS ASSESSED USING THE PEDRO SCALE. RESULTS: TWELVE TRIALS OF HIGH METHODOLOGICAL QUALITY (MEAN PEDRO SCORE 6.1), TOTALLING 752 PARTICIPANTS, WERE IDENTIFIED AND PROVIDED DATA FOR THE META-ANALYSIS. YOGA PRODUCED A MEDIUM EFFECT ON HRQOL (HEDGES' G = 0.51, 95% CI 0.25-0.76, 12 TRIALS) AND A SMALL EFFECT ON MENTAL WELL-BEING (HEDGES' G = 0.38, 95% CI 0.15-0.62, 12 TRIALS). CONCLUSION: YOGA INTERVENTIONS RESULTED IN SMALL TO MODERATE IMPROVEMENTS IN BOTH HRQOL AND MENTAL WELL-BEING IN PEOPLE AGED 60+ YEARS. FURTHER, RESEARCH IS NEEDED TO DETERMINE THE OPTIMAL DOSE OF YOGA TO MAXIMISE HEALTH IMPACT. PROSPERO REGISTRATION NUMBER: (CRD42016052458). 2018 9 1061 39 EFFECTS OF YOGA ON HEALTH-RELATED QUALITY, PHYSICAL HEALTH AND PSYCHOLOGICAL HEALTH IN WOMEN WITH BREAST CANCER RECEIVING CHEMOTHERAPY: A SYSTEMATIC REVIEW AND META-ANALYSIS. BACKGROUND: YOGA RECEIVE MORE ATTENTION FROM BREAST CANCER PATIENTS, HOWEVER ITS FEASIBILITY AND EFFICACY DURING CHEMOTHERAPY REMAINS CONFLICTING. WE PERFORMED THIS SYSTEMATIC REVIEW TO ASSESS THE EFFECTS OF YOGA ON HEALTH-RELATED QUALITY, PHYSICAL HEALTH AND PSYCHOLOGICAL HEALTH IN BREAST CANCER PATIENTS UNDERGOING CHEMOTHERAPY. METHODS: A SYSTEMATIC SEARCH WAS CONDUCTED TO RETRIEVE RANDOMIZED CONTROLLED TRIALS (RCTS) WHICH INVESTIGATED THE COMPARATIVE EFFICACY OF YOGA VERSUS COMPARATORS SUCH AS USUAL CARE AMONG BREAST CANCER PATIENTS FOR HEALTH-RELATED QUALITY, PHYSICAL HEALTH AND PSYCHOLOGICAL HEALTH IN PUBMED, EMBASE, COCHRANE CENTRAL REGISTER OF CONTROLLED TRIALS (CNETRAL), NURSING AND ALLIED HEALTH LITERATURE (CINAHL), CHINESE BIOMEDICAL LITERATURE (CBM) DATABASE, CHINA SCIENCE AND TECHNOLOGY JOURNAL (CSTJ) DATABASE, CHINA NATIONAL KNOWLEDGE INFRASTRUCTURE (CNKI), AND WANGFANG DATABASE FROM INCEPTION TO DECEMBER 2018. THE LATEST SEARCH WAS UPDATED ON SEPTEMBER 2020. ALL ANALYSES WERE COMPLETED USING REVMAN VERSION 5.3. RESULTS: SEVEN TRIALS INVOLVING 693 BREAST CANCER PATIENTS MET INCLUSION CRITERIA. META-ANALYSIS INDICATED A SHORT-TERM IMPROVEMENT IN FATIGUE [STANDARD MEAN DIFFERENCE (SMD), -0.62; 95% CONFIDENCE INTERVAL (CI), -1.17 TO -0.07], SLEEP DISTURBANCE (SMD, -0.34; 95% CI, -0.55 TO -0.12), DEPRESSION (SMD, -0.50; 95% CI, -0.70 TO -0.31) ANXIETY (SMD, -0.50; 95% CI, -0.70 TO -0.31), AND HEALTH-RELATED QUALITY OF LIFE (QOL) (SMD, 0.72; 95% CI, -0.12 TO 1.56) IN THE YOGA GROUP; HOWEVER BENEFICIAL MEDIUM- AND LONG-TERM EFFECTS IN FATIGUE, SLEEP DISTURBANCE WERE NOT IDENTIFIED. MOREOVER, QUALITATIVE ANALYSES SUGGESTED THAT YOGA WAS NOT ASSOCIATED WITH DECREASED ADVERSE EVENTS (AES) COMPARED WITH CONTROL GROUPS. CONCLUSIONS: YOGA MAY BENEFIT TO REDUCE FATIGUE, DEPRESSION AND ANXIETY, IMPROVE SLEEP DISTURBANCE, AND IMPROVE QOL IN BREAST CANCER PATIENTS RECEIVING CHEMOTHERAPY IN THE SHORT-TERM; HOWEVER, MEDIUM- AND LONG-TERM EFFECTS SHOULD BE FURTHER ESTABLISHED OWING TO LIMITATIONS. 2021 10 2614 37 YOGA FOR SCHIZOPHRENIA: A SYSTEMATIC REVIEW AND META-ANALYSIS. BACKGROUND: THE AIM OF THIS REVIEW WAS TO SYSTEMATICALLY REVIEW AND META-ANALYZE THE EFFECTS OF YOGA ON SYMPTOMS OF SCHIZOPHRENIA, QUALITY OF LIFE, FUNCTION, AND HOSPITALIZATION IN PATIENTS WITH SCHIZOPHRENIA. METHODS: MEDLINE/PUBMED, SCOPUS, THE COCHRANE LIBRARY, PSYCINFO, AND INDMED WERE SCREENED THROUGH AUGUST 2012. RANDOMIZED CONTROLLED TRIALS (RCTS) COMPARING YOGA TO USUAL CARE OR NON-PHARMACOLOGICAL INTERVENTIONS WERE ANALYZED WHEN THEY ASSESSED SYMPTOMS OR QUALITY OF LIFE IN PATIENTS WITH SCHIZOPHRENIA. COGNITIVE FUNCTION, SOCIAL FUNCTION, HOSPITALIZATION, AND SAFETY WERE DEFINED AS SECONDARY OUTCOMES. RISK OF BIAS WAS ASSESSED USING THE RISK OF BIAS TOOL RECOMMENDED BY THE COCHRANE BACK REVIEW GROUP. STANDARDIZED MEAN DIFFERENCES (SMD) AND 95% CONFIDENCE INTERVALS (CI) WERE CALCULATED. RESULTS: FIVE RCTS WITH A TOTAL OF 337 PATIENTS WERE INCLUDED; 2 RCTS HAD LOW RISK OF BIAS. TWO RCTS COMPARED YOGA TO USUAL CARE; 1 RCT COMPARED YOGA TO EXERCISE; AND 2 3-ARM RCTS COMPARED YOGA TO USUAL CARE AND EXERCISE. NO EVIDENCE WAS FOUND FOR SHORT-TERM EFFECTS OF YOGA COMPARED TO USUAL CARE ON POSITIVE SYMPTOMS (SMD = -0.58; 95% CI -1.52 TO 0.37; P = 0.23), OR NEGATIVE SYMPTOMS (SMD = -0.59; 95% CI -1.87 TO 0.69; P = 0.36). MODERATE EVIDENCE WAS FOUND FOR SHORT-TERM EFFECTS ON QUALITY OF LIFE COMPARED TO USUAL CARE (SMD = 2.28; 95% CI 0.42 TO 4.14; P = 0.02). THESE EFFECTS WERE ONLY PRESENT IN STUDIES WITH HIGH RISK OF BIAS. NO EVIDENCE WAS FOUND FOR SHORT-TERM EFFECTS ON SOCIAL FUNCTION (SMD = 1.20; 95% CI -0.78 TO 3.18; P = 0.23). COMPARING YOGA TO EXERCISE, NO EVIDENCE WAS FOUND FOR SHORT-TERM EFFECTS ON POSITIVE SYMPTOMS (SMD = -0.35; 95% CI -0.75 TO 0.05; P = 0.09), NEGATIVE SYMPTOMS (SMD = -0.28; 95% CI -1.42 TO 0.86; P = 0.63), QUALITY OF LIFE (SMD = 0.17; 95% CI -0.27 TO 0.61; P = 0.45), OR SOCIAL FUNCTION (SMD = 0.20; 95% CI -0.27 TO 0.67; P = 0.41). ONLY 1 RCT REPORTED ADVERSE EVENTS. CONCLUSIONS: THIS SYSTEMATIC REVIEW FOUND ONLY MODERATE EVIDENCE FOR SHORT-TERM EFFECTS OF YOGA ON QUALITY OF LIFE. AS THESE EFFECTS WERE NOT CLEARLY DISTINGUISHABLE FROM BIAS AND SAFETY OF THE INTERVENTION WAS UNCLEAR, NO RECOMMENDATION CAN BE MADE REGARDING YOGA AS A ROUTINE INTERVENTION FOR SCHIZOPHRENIA PATIENTS. 2013 11 1054 34 EFFECTS OF YOGA ON CHRONIC NECK PAIN: A SYSTEMATIC REVIEW AND META-ANALYSIS. OBJECTIVE: THE AIM OF THIS REVIEW WAS TO SYSTEMATICALLY ASSESS AND META-ANALYZE THE EFFECTIVENESS OF YOGA IN RELIEVING CHRONIC NECK PAIN. METHODS: PUBMED/MEDLINE, THE COCHRANE LIBRARY, SCOPUS, AND INDMED WERE SCREENED THROUGH JANUARY 2017 FOR RANDOMIZED CONTROLLED TRIALS ASSESSING NECK PAIN INTENSITY AND/OR NECK PAIN-RELATED DISABILITY IN CHRONIC NECK PAIN PATIENTS. SECONDARY OUTCOME MEASURES INCLUDED QUALITY OF LIFE, MOOD, AND SAFETY. RISK OF BIAS WAS ASSESSED USING THE COCHRANE TOOL. RESULTS: THREE STUDIES ON 188 PATIENTS WITH CHRONIC NON-SPECIFIC NECK PAIN COMPARING YOGA TO USUAL CARE WERE INCLUDED. TWO STUDIES HAD OVERALL LOW RISK OF BIAS; AND ONE HAD HIGH OR UNCLEAR RISK OF BIAS FOR SEVERAL DOMAINS. EVIDENCE FOR SHORT-TERM EFFECTS WAS FOUND FOR NECK PAIN INTENSITY (STANDARDIZED MEAN DIFFERENCE (SMD) = -1.28; 95% CONFIDENCE INTERVAL (CI) = -1.18, -0.75; P < 0.001), NECK PAIN-RELATED DISABILITY (SMD = -0.97; 95% CI = -1.44, -0.50; P < 0.001), QUALITY OF LIFE (SMD = 0.57; 95% CI = 0.17, 0.197; P = 0.005), AND MOOD (SMD = -1.02; 95% CI = -1.38, -0.65; P < 0.001). EFFECTS WERE ROBUST AGAINST POTENTIAL METHODOLOGICAL BIAS AND DID NOT DIFFER BETWEEN DIFFERENT INTERVENTION SUBGROUPS. IN THE TWO STUDIES THAT INCLUDED SAFETY DATA, NO SERIOUS ADVERSE EVENTS OCCURRED. CONCLUSION: YOGA HAS SHORT-TERM EFFECTS ON CHRONIC NECK PAIN, ITS RELATED DISABILITY, QUALITY OF LIFE, AND MOOD SUGGESTING THAT YOGA MIGHT BE A GOOD TREATMENT OPTION. 2017 12 2597 39 YOGA FOR MULTIPLE SCLEROSIS: A SYSTEMATIC REVIEW AND META-ANALYSIS. WHILE YOGA SEEMS TO BE EFFECTIVE IN A NUMBER OF NEUROPSYCHIATRIC DISORDERS, THE EVIDENCE OF EFFICACY IN MULTIPLE SCLEROSIS REMAINS UNCLEAR. THE AIM OF THIS REVIEW WAS TO SYSTEMATICALLY ASSESS AND META-ANALYZE THE AVAILABLE DATA ON EFFICACY AND SAFETY OF YOGA IN PATIENTS WITH MULTIPLE SCLEROSIS. MEDLINE/PUBMED, SCOPUS, THE COCHRANE CENTRAL REGISTER OF CONTROLLED TRIALS, PSYCINFO, CAM-QUEST, CAMBASE, AND INDMED WERE SEARCHED THROUGH MARCH 2014. RANDOMIZED CONTROLLED TRIALS (RCTS) OF YOGA FOR PATIENTS WITH MULTIPLE SCLEROSIS WERE INCLUDED IF THEY ASSESSED HEALTH-RELATED QUALITY OF LIFE, FATIGUE, AND/OR MOBILITY. MOOD, COGNITIVE FUNCTION, AND SAFETY WERE DEFINED AS SECONDARY OUTCOME MEASURES. RISK OF BIAS WAS ASSESSED USING THE COCHRANE TOOL. SEVEN RCTS WITH A TOTAL OF 670 PATIENTS WERE INCLUDED. EVIDENCE FOR SHORT-TERM EFFECTS OF YOGA COMPARED TO USUAL CARE WERE FOUND FOR FATIGUE (STANDARDIZED MEAN DIFFERENCE [SMD] = -0.52; 95% CONFIDENCE INTERVALS (CI) = -1.02 TO -0.02; P = 0.04; HETEROGENEITY: I2 = 60%; CHI2 = 7.43; P = 0.06) AND MOOD (SMD = -0.55; 95%CI = -0.96 TO -0.13; P = 0.01; HETEROGENEITY: I2 = 0%; CHI2 = 1.25; P = 0.53), BUT NOT FOR HEALTH-RELATED QUALITY OF LIFE, MUSCLE FUNCTION, OR COGNITIVE FUNCTION. THE EFFECTS ON FATIGUE AND MOOD WERE NOT ROBUST AGAINST BIAS. NO SHORT-TERM OR LONGER TERM EFFECTS OF YOGA COMPARED TO EXERCISE WERE FOUND. YOGA WAS NOT ASSOCIATED WITH SERIOUS ADVERSE EVENTS. IN CONCLUSION, SINCE NO METHODOLOGICAL SOUND EVIDENCE WAS FOUND, NO RECOMMENDATION CAN BE MADE REGARDING YOGA AS A ROUTINE INTERVENTION FOR PATIENTS WITH MULTIPLE SCLEROSIS. YOGA MIGHT BE CONSIDERED A TREATMENT OPTION FOR PATIENTS WHO ARE NOT ADHERENT TO RECOMMENDED EXERCISE REGIMENS. 2014 13 1038 32 EFFECTS OF YOGA IN PATIENTS WITH CHRONIC HEART FAILURE: A META-ANALYSIS. THE USE OF YOGA AS AN EFFECTIVE CARDIAC REHABILITATION IN PATIENTS WITH CHRONIC HEART FAILURE (CHF) REMAINS CONTROVERSIAL. WE PERFORMED A META-ANALYSIS TO EXAMINE THE EFFECTS OF YOGA ON EXERCISE CAPACITY AND HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN PATIENTS WITH CHF. METHODS: WE SEARCHED MEDLINE, COCHRANE CENTRAL REGISTER OF CONTROLLED TRIALS, EXCERPTA MEDICA DATABASE, LILACS, PHYSIOTHERAPY EVIDENCE DATABASE, THE SCIENTIFIC ELECTRONIC LIBRARY ONLINE, AND CUMULATIVE INDEX TO NURSING AND ALLIED HEALTH (FROM THE EARLIEST DATE AVAILABLE TO DECEMBER 2013) FOR RANDOMIZED CONTROLLED TRIALS (RCTS) EXAMINING THE EFFECTS OF YOGA VERSUS EXERCISE AND/OR OF YOGA VERSUS CONTROL ON EXERCISE CAPACITY (PEAKVO2) AND QUALITY-OF-LIFE (HRQOL) IN CHF. TWO REVIEWERS SELECTED STUDIES INDEPENDENTLY. WEIGHTED MEAN DIFFERENCES (WMDS) AND 95% CONFIDENCE INTERVALS (CIS) WERE CALCULATED, AND HETEROGENEITY WAS ASSESSED USING THE I2 TEST. TWO STUDIES MET THE SELECTION CRITERIA (TOTAL: 30 YOGA AND 29 CONTROL PATIENTS). THE RESULTS SUGGESTED THAT YOGA COMPARED WITH CONTROL HAD A POSITIVE IMPACT ON PEAK VO2 AND HRQOL. PEAK VO2, WMD (3.87 95% CI: 1.95 TO 5.80), AND GLOBAL HRQOL STANDARDIZED MEAN DIFFERENCES (-12.46 95% CI: -22.49 TO -2.43) IMPROVED IN THE YOGA GROUP COMPARED TO THE CONTROL GROUP. YOGA ENHANCES PEAK VO2 AND HRQOL IN PATIENTS WITH CHF AND COULD BE CONSIDERED FOR INCLUSION IN CARDIAC REHABILITATION PROGRAMS. LARGER RCTS ARE REQUIRED TO FURTHER INVESTIGATE THE EFFECTS OF YOGA IN PATIENTS WITH CHF. 2014 14 227 32 A SYSTEMATIC REVIEW OF THE EFFECT OF LAUGHTER YOGA ON PHYSICAL FUNCTION AND PSYCHOSOCIAL OUTCOMES IN OLDER ADULTS. BACKGROUND: LAUGHTER YOGA IS ONE OF THE INCREASINGLY USED METHODS AMONG COMPLEMENTARY HEALTH APPROACHES IN THE WORLD. THE AIM OF THIS STUDY WAS TO DETERMINE THE EFFECTIVENESS OF LAUGHTER YOGA ON PHYSICAL FUNCTION AND PSYCHOSOCIAL OUTCOMES IN OLDER ADULTS. METHODS: IN THIS SYSTEMATIC REVIEW, ELECTRONIC SEARCHES WERE PERFORMED IN CINAHL, WEB OF SCIENCE, COCHRANE, SCOPUS, PROQUEST DATABASES FROM MAY 2010 TO MAY 2020. THE SCREENING PROCESS WAS CONDUCTED BY TWO AUTHORS INDEPENDENTLY AND FINALLY AGREED TOGETHER. THE REVIEW WAS REPORTED ACCORDING TO PRISMA GUIDELINE. RESULTS: A TOTAL OF 3210 STUDIES WERE EXAMINED, AND SEVEN PUBLICATIONS (SIX QUASI EXPERIMENTAL AND ONE RANDOMIZED CONTROL TRIAL), IN ACCORDANCE WITH THE INCLUSION CRITERIA WERE INCLUDED IN THE STUDY AND EVALUATED. THE RESULTS INDICATED THAT SIGNIFICANT DIFFERENCES WERE FOUND IN THE EFFECTIVENESS OF LAUGHTER YOGA ON PHYSICAL FUNCTION (BLOOD PRESSURE, CORTISOL LEVEL, SLEEP QUALITY) AND PSYCHOSOCIAL HEALTH (LIFE SATISFACTION, QUALITY OF LIFE, LONELINESS, DEATH ANXIETY, DEPRESSION, MOOD, HAPPINESS) IN OLDER ADULTS. CONCLUSION: LAUGHTER YOGA IS A COST-EFFECTIVE AND NO ADVERSE EFFECT IN OLDER ADULTS. IT CAN BE USED FOR HEALTH PROMOTION FOR OLDER ADULTS. 2020 15 2546 37 YOGA FOR BREAST CANCER PATIENTS AND SURVIVORS: A SYSTEMATIC REVIEW AND META-ANALYSIS. BACKGROUND: MANY BREAST CANCER PATIENTS AND SURVIVORS USE YOGA TO COPE WITH THEIR DISEASE. THE AIM OF THIS REVIEW WAS TO SYSTEMATICALLY ASSESS AND META-ANALYZE THE EVIDENCE FOR EFFECTS OF YOGA ON HEALTH-RELATED QUALITY OF LIFE AND PSYCHOLOGICAL HEALTH IN BREAST CANCER PATIENTS AND SURVIVORS. METHODS: MEDLINE, PSYCINFO, EMBASE, CAMBASE, AND THE COCHRANE LIBRARY WERE SCREENED THROUGH FEBRUARY 2012. RANDOMIZED CONTROLLED TRIALS (RCTS) COMPARING YOGA TO CONTROLS WERE ANALYZED WHEN THEY ASSESSED HEALTH-RELATED QUALITY OF LIFE OR PSYCHOLOGICAL HEALTH IN BREAST CANCER PATIENTS OR SURVIVORS. RISK OF BIAS WAS ASSESSED USING THE COCHRANE RISK OF BIAS TOOL. STANDARDIZED MEAN DIFFERENCES (SMD) AND 95% CONFIDENCE INTERVALS (CI) WERE CALCULATED. RESULTS: TWELVE RCTS WITH A TOTAL OF 742 PARTICIPANTS WERE INCLUDED. SEVEN RCTS COMPARED YOGA TO NO TREATMENT; 3 RCTS COMPARED YOGA TO SUPPORTIVE THERAPY; 1 RCT COMPARED YOGA TO HEALTH EDUCATION; AND 1 RCT COMPARED A COMBINATION OF PHYSIOTHERAPY AND YOGA TO PHYSIOTHERAPY ALONE. EVIDENCE WAS FOUND FOR SHORT-TERM EFFECTS ON GLOBAL HEALTH-RELATED QUALITY OF LIFE (SMD = 0.62 [95% CI: 0.04 TO 1.21]; P = 0.04), FUNCTIONAL (SMD = 0.30 [95% CI: 0.03 TO 0.57), SOCIAL (SMD = 0.29 [95% CI: 0.08 TO 0.50]; P < 0.01), AND SPIRITUAL WELL-BEING (SMD = 0.41 [95% CI: 0.08; 0.74]; P = 0.01). THESE EFFECTS WERE, HOWEVER, ONLY PRESENT IN STUDIES WITH UNCLEAR OR HIGH RISK OF SELECTION BIAS. SHORT-TERM EFFECTS ON PSYCHOLOGICAL HEALTH ALSO WERE FOUND: ANXIETY (SMD = -1.51 [95% CI: -2.47; -0.55]; P < 0.01), DEPRESSION (SMD = -1.59 [95% CI: -2.68 TO -0.51]; P < 0.01), PERCEIVED STRESS (SMD = -1.14 [95% CI:-2.16; -0.12]; P = 0.03), AND PSYCHOLOGICAL DISTRESS (SMD = -0.86 [95% CI:-1.50; -0.22]; P < 0.01). SUBGROUP ANALYSES REVEALED EVIDENCE OF EFFICACY ONLY FOR YOGA DURING ACTIVE CANCER TREATMENT BUT NOT AFTER COMPLETION OF ACTIVE TREATMENT. CONCLUSIONS: THIS SYSTEMATIC REVIEW FOUND EVIDENCE FOR SHORT-TERM EFFECTS OF YOGA IN IMPROVING PSYCHOLOGICAL HEALTH IN BREAST CANCER PATIENTS. THE SHORT-TERM EFFECTS ON HEALTH-RELATED QUALITY OF LIFE COULD NOT BE CLEARLY DISTINGUISHED FROM BIAS. YOGA CAN BE RECOMMENDED AS AN INTERVENTION TO IMPROVE PSYCHOLOGICAL HEALTH DURING BREAST CANCER TREATMENT. 2012 16 2883 35 YOGA: A TOOL FOR IMPROVING THE QUALITY OF LIFE IN CHRONIC PANCREATITIS. AIM: TO DETERMINE THE EFFECTIVENESS OF YOGA ON IMPROVING THE QUALITY OF LIFE IN PATIENTS OF CHRONIC PANCREATITIS. METHODS: THE PATIENTS WERE RANDOMIZED TO TWO GROUPS. THE CONTROL GROUP CONTINUED THEIR USUAL CARE AS DIRECTED BY THEIR PHYSICIANS. PATIENTS IN THE YOGA GROUP, IN ADDITION, RECEIVED BIWEEKLY YOGA SESSIONS FOR 12 WK. THE PATIENTS' DEMOGRAPHIC AND HEALTH BEHAVIOUR VARIABLES WERE ASSESSED BEFORE AND AFTER THE YOGA PROGRAMME USING MEDICAL OUTCOMES SHORT FORM (SF-36) FOR QUALITY OF LIFE, PROFILE OF MOOD STATES FOR ASSESSING MOOD AND SYMPTOMS OF STRESS INVENTORY FOR MEASURING STRESS. RESULTS: A TOTAL OF 60 PATIENTS WERE ENROLLED, WITH 8 DROP-OUTS. THIRTY PATIENTS WERE RANDOMIZED TO THE YOGA GROUP AND 30 TO THE CONTROL GROUP. SIGNIFICANT IMPROVEMENTS WERE SEEN IN OVERALL QUALITY OF LIFE, SYMPTOMS OF STRESS, MOOD CHANGES, ALCOHOL DEPENDENCE AND APPETITE AFTER THE 12 WK PERIOD APART FROM THE GENERAL FEELING OF WELL-BEING AND DESIRE TO CONTINUE WITH THE PROGRAMME IN FUTURE IN THE YOGA GROUP, WHILE THERE WAS NO DIFFERENCE IN THE CONTROL GROUP. CONCLUSION: YOGA IS EFFECTIVE ON IMPROVING THE QUALITY OF LIFE IN PATIENTS OF CHRONIC PANCREATITIS. 2007 17 923 39 EFFECTIVENESS OF YOGA FOR MENOPAUSAL SYMPTOMS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS. OBJECTIVES. TO SYSTEMATICALLY REVIEW AND META-ANALYZE THE EFFECTIVENESS OF YOGA FOR MENOPAUSAL SYMPTOMS. METHODS. MEDLINE, SCOPUS, THE COCHRANE LIBRARY, AND PSYCINFO WERE SCREENED THROUGH APRIL 2012. RANDOMIZED CONTROLLED TRIALS (RCTS) WERE INCLUDED IF THEY ASSESSED THE EFFECT OF YOGA ON MAJOR MENOPAUSAL SYMPTOMS, NAMELY, (1) PSYCHOLOGICAL SYMPTOMS, (2) SOMATIC SYMPTOMS, (3) VASOMOTOR SYMPTOMS, AND/OR (4) UROGENITAL SYMPTOMS. FOR EACH OUTCOME, STANDARDIZED MEAN DIFFERENCES (SMDS) AND 95% CONFIDENCE INTERVALS (CIS) WERE CALCULATED. TWO AUTHORS INDEPENDENTLY ASSESSED RISK OF BIAS USING THE RISK OF BIAS TOOL RECOMMENDED BY THE COCHRANE BACK REVIEW GROUP. RESULTS. FIVE RCTS WITH 582 PARTICIPANTS WERE INCLUDED IN THE QUALITATIVE REVIEW, AND 4 RCTS WITH 545 PARTICIPANTS WERE INCLUDED IN THE META-ANALYSIS. THERE WAS MODERATE EVIDENCE FOR SHORT-TERM EFFECTS ON PSYCHOLOGICAL SYMPTOMS (SMD = -0.37; 95% CI -0.67 TO -0.07; P = 0.02). NO EVIDENCE WAS FOUND FOR TOTAL MENOPAUSAL SYMPTOMS, SOMATIC SYMPTOMS, VASOMOTOR SYMPTOMS, OR UROGENITAL SYMPTOMS. YOGA WAS NOT ASSOCIATED WITH SERIOUS ADVERSE EVENTS. CONCLUSION. THIS SYSTEMATIC REVIEW FOUND MODERATE EVIDENCE FOR SHORT-TERM EFFECTIVENESS OF YOGA FOR PSYCHOLOGICAL SYMPTOMS IN MENOPAUSAL WOMEN. WHILE MORE RIGOROUS RESEARCH IS NEEDED TO UNDERPIN THESE RESULTS, YOGA CAN BE PRELIMINARILY RECOMMENDED AS AN ADDITIONAL INTERVENTION FOR WOMEN WHO SUFFER FROM PSYCHOLOGICAL COMPLAINTS ASSOCIATED WITH MENOPAUSE. 2012 18 793 41 EFFECT OF YOGA IN THE THERAPY OF IRRITABLE BOWEL SYNDROME: A SYSTEMATIC REVIEW. BACKGROUND & AIMS: THIS REVIEW AIMS TO SYSTEMATICALLY SURVEY THE EFFECTS OF YOGA ON SYMPTOMS OF IRRITABLE BOWEL SYNDROME (IBS), PAIN, QUALITY OF LIFE, MOOD, STRESS, AND SAFETY IN PATIENTS WITH IBS. METHODS: MEDLINE/PUBMED, SCOPUS, THE COCHRANE LIBRARY, CAM-QUEST, CAMBASE, AND INDMED WERE SCREENED THROUGH NOVEMBER 2015. RANDOMIZED CONTROLLED TRIALS COMPARING YOGA WITH USUAL CARE, NONPHARMACOLOGIC, OR PHARMACOLOGIC INTERVENTIONS WERE ANALYZED FOR PATIENTS WITH IBS. PRIMARY OUTCOMES INCLUDED GASTROINTESTINAL SYMPTOMS, QUALITY OF LIFE, AND PAIN. ANXIETY, MOOD, AND SAFETY WERE DEFINED AS SECONDARY OUTCOMES. RISK OF BIAS WAS ASSESSED ACCORDING TO THE COCHRANE COLLABORATION RECOMMENDATIONS. RESULTS: SIX RANDOMIZED CONTROLLED TRIALS WITH A TOTAL OF 273 PATIENTS WERE INCLUDED IN THE QUALITATIVE ANALYSIS. THERE WAS EVIDENCE FOR A BENEFICIAL EFFECT OF A YOGIC INTERVENTION OVER CONVENTIONAL TREATMENT IN IBS, WITH SIGNIFICANTLY DECREASED BOWEL SYMPTOMS, IBS SEVERITY, AND ANXIETY. FURTHERMORE, THERE WERE SIGNIFICANT IMPROVEMENTS IN QUALITY OF LIFE, GLOBAL IMPROVEMENT, AND PHYSICAL FUNCTIONING AFTER YOGA COMPARED WITH NO TREATMENT. TWO RANDOMIZED CONTROLLED TRIALS REPORTED SAFETY DATA STATING THAT NO ADVERSE EVENTS OCCURRED. OVERALL, RISK OF BIAS OF THE INCLUDED STUDIES WAS UNCLEAR. CONCLUSIONS: THE FINDINGS OF THIS SYSTEMATIC REVIEW SUGGEST THAT YOGA MIGHT BE A FEASIBLE AND SAFE ADJUNCTIVE TREATMENT FOR PEOPLE WITH IBS. NEVERTHELESS, NO RECOMMENDATION CAN BE MADE REGARDING YOGA AS A ROUTINE INTERVENTION FOR PATIENTS WITH IBS BECAUSE OF MAJOR FLAWS IN STUDY METHODS. MORE RESEARCH IS NEEDED WITH RESPECT TO A HIGH-QUALITY STUDY DESIGN AND CONSENSUS IN CLINICAL OUTCOME MEASUREMENTS IN IBS. CLINICALTRIALS.GOV NUMBER, NCT02721836. 2016 19 2859 30 YOGA-BASED EXERCISE IMPROVES BALANCE AND MOBILITY IN PEOPLE AGED 60 AND OVER: A SYSTEMATIC REVIEW AND META-ANALYSIS. OBJECTIVE: ONE-THIRD OF COMMUNITY-DWELLING OLDER ADULTS FALL ANNUALLY. EXERCISE THAT CHALLENGES BALANCE IS PROVEN TO PREVENT FALLS. WE CONDUCTED A SYSTEMATIC REVIEW WITH META-ANALYSIS TO DETERMINE THE IMPACT OF YOGA-BASED EXERCISE ON BALANCE AND PHYSICAL MOBILITY IN PEOPLE AGED 60+ YEARS. METHODS: SEARCHES FOR RELEVANT TRIALS WERE CONDUCTED ON THE FOLLOWING ELECTRONIC DATABASES: MEDLINE, EMBASE, COCHRANE CENTRAL REGISTER OF CONTROLLED TRIALS, CINAHL, ALLIED AND COMPLEMENTARY MEDICINE DATABASE AND THE PHYSIOTHERAPY EVIDENCE DATABASE (PEDRO) FROM INCEPTION TO FEBRUARY 2015. TRIALS WERE INCLUDED IF THEY EVALUATED THE EFFECT OF PHYSICAL YOGA (EXCLUDING MEDITATION AND BREATHING EXERCISES ALONE) ON BALANCE IN PEOPLE AGED 60+ YEARS. WE EXTRACTED DATA ON BALANCE AND THE SECONDARY OUTCOME OF PHYSICAL MOBILITY. STANDARDISED MEAN DIFFERENCES AND 95% CONFIDENCE INTERVALS (CI) WERE CALCULATED USING RANDOM-EFFECTS MODELS. METHODOLOGICAL QUALITY OF TRIALS WAS ASSESSED USING THE 10-POINT PHYSIOTHERAPY EVIDENCE DATABASE (PEDRO) SCALE. RESULTS: SIX TRIALS OF RELATIVELY HIGH METHODOLOGICAL QUALITY, TOTALLING 307 PARTICIPANTS, WERE IDENTIFIED AND HAD DATA THAT COULD BE INCLUDED IN A META-ANALYSIS. OVERALL, YOGA INTERVENTIONS HAD A SMALL EFFECT ON BALANCE PERFORMANCE (HEDGES' G = 0.40, 95% CI 0.15-0.65, 6 TRIALS) AND A MEDIUM EFFECT ON PHYSICAL MOBILITY (HEDGES' G = 0.50, 95% CI 0.06-0.95, 3 TRIALS). CONCLUSION: YOGA INTERVENTIONS RESULTED IN SMALL IMPROVEMENTS IN BALANCE AND MEDIUM IMPROVEMENTS IN PHYSICAL MOBILITY IN PEOPLE AGED 60+ YEARS. FURTHER RESEARCH IS REQUIRED TO DETERMINE WHETHER YOGA-RELATED IMPROVEMENTS IN BALANCE AND MOBILITY TRANSLATE TO PREVENTION OF FALLS IN OLDER PEOPLE. PROSPERO REGISTRATION NUMBER CRD42015015872. 2016 20 1740 42 PHYSICAL AND PSYCHOSOCIAL BENEFITS OF YOGA IN CANCER PATIENTS AND SURVIVORS, A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS. BACKGROUND: THIS STUDY AIMED TO SYSTEMATICALLY REVIEW THE EVIDENCE FROM RANDOMIZED CONTROLLED TRIALS (RCTS) AND TO CONDUCT A META-ANALYSIS OF THE EFFECTS OF YOGA ON PHYSICAL AND PSYCHOSOCIAL OUTCOMES IN CANCER PATIENTS AND SURVIVORS. METHODS: A SYSTEMATIC LITERATURE SEARCH IN TEN DATABASES WAS CONDUCTED IN NOVEMBER 2011. STUDIES WERE INCLUDED IF THEY HAD AN RCT DESIGN, FOCUSED ON CANCER PATIENTS OR SURVIVORS, INCLUDED PHYSICAL POSTURES IN THE YOGA PROGRAM, COMPARED YOGA WITH A NON-EXERCISE OR WAITLIST CONTROL GROUP, AND EVALUATED PHYSICAL AND/OR PSYCHOSOCIAL OUTCOMES. TWO RESEARCHERS INDEPENDENTLY RATED THE QUALITY OF THE INCLUDED RCTS, AND HIGH QUALITY WAS DEFINED AS >50% OF THE TOTAL POSSIBLE SCORE. EFFECT SIZES (COHEN'S D) WERE CALCULATED FOR OUTCOMES STUDIED IN MORE THAN THREE STUDIES AMONG PATIENTS WITH BREAST CANCER USING MEANS AND STANDARD DEVIATIONS OF POST-TEST SCORES OF THE INTERVENTION AND CONTROL GROUPS. RESULTS: SIXTEEN PUBLICATIONS OF 13 RCTS MET THE INCLUSION CRITERIA, OF WHICH ONE INCLUDED PATIENTS WITH LYMPHOMAS AND THE OTHERS FOCUSED ON PATIENTS WITH BREAST CANCER. THE MEDIAN QUALITY SCORE WAS 67% (RANGE: 22-89%). THE INCLUDED STUDIES EVALUATED 23 PHYSICAL AND 20 PSYCHOSOCIAL OUTCOMES. OF THE OUTCOMES STUDIED IN MORE THAN THREE STUDIES AMONG PATIENTS WITH BREAST CANCER, WE FOUND LARGE REDUCTIONS IN DISTRESS, ANXIETY, AND DEPRESSION (D = -0.69 TO -0.75), MODERATE REDUCTIONS IN FATIGUE (D = -0.51), MODERATE INCREASES IN GENERAL QUALITY OF LIFE, EMOTIONAL FUNCTION AND SOCIAL FUNCTION (D = 0.33 TO 0.49), AND A SMALL INCREASE IN FUNCTIONAL WELL-BEING (D = 0.31). EFFECTS ON PHYSICAL FUNCTION AND SLEEP WERE SMALL AND NOT SIGNIFICANT. CONCLUSION: YOGA APPEARED TO BE A FEASIBLE INTERVENTION AND BENEFICIAL EFFECTS ON SEVERAL PHYSICAL AND PSYCHOSOCIAL SYMPTOMS WERE REPORTED. IN PATIENTS WITH BREAST CANCER, EFFECT SIZE ON FUNCTIONAL WELL-BEING WAS SMALL, AND THEY WERE MODERATE TO LARGE FOR PSYCHOSOCIAL OUTCOMES. 2012